VeriMomIst hypericum perforatum leaf extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
Pregnancy-safe products containing hypericum perforatum leaf extract
Related ingredients
Frequently asked questions
- Ist hypericum perforatum leaf extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
- Ist hypericum perforatum leaf extract während des Stillens sicher?
- No regulatory harmonised reproductive/breastfeeding classification. While oral St. John's wort is known for systemic drug interactions and there are reports of transfer with systemic use, topical cosmetic use of the leaf extract is not established to cause significant transfer into breastmilk; therefore hazard and mechanism are scored 0 and exposure is low but measurable (e=1). Sources: PubMed (systemic use literature), CosIng, ECHA (no harmonised CLP).
- Ist hypericum perforatum leaf extract sicher für Babyhaut?
- No evidence of a reproductive or developmental hazard specific to infants from topical exposure to Hypericum perforatum leaf extract; mechanism of reproductive toxicity is not demonstrated. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight, dermal exposure is increased relative to adults, so exposure is increased to moderate (adult e=1 → infant e=2). Note: phototoxic constituents (e.g., hypericin) may increase skin reaction risk but that is separate from reproductive classification. Sources: CosIng, PubMed (phototoxicity literature), ECHA (no harmonised CLP).
- Wie bewertet VeriMom hypericum perforatum leaf extract?
- VeriMom bewertet hypericum perforatum leaf extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu hypericum perforatum leaf extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu hypericum perforatum leaf extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.